Abstract:Crouzon syndrome, caused by FGFR2 mutations, leads to premature cranial suture fusion and abnormal head shapes. This study used FGFR2C342Y mice to examine the mutation's effect on cranial bone microarchitecture during postnatal development. High‐resolution imaging of frontal and parietal bones in mutant and wild‐type mice revealed significant differences in bone volume fraction, canal and lacunar morphometry, especially in frontal bones. Mutants had larger, less dense lacunae around postnatal days 7–14. These findings improve understanding of Crouzon syndrome and aid in enhancing surgical outcomes. Crouzon syndrome is a congenital craniofacial disorder caused by mutations in the Fibroblast Growth Factor Receptor 2 (FGFR2). It is characterized by the premature fusion of cranial sutures, leading to a brachycephalic head shape, and midfacial hypoplasia. The aim of this study was to investigate the effect of the FGFR2 mutation on the microarchitecture of cranial bones at different stages of postnatal skull development, using the FGFR2C342Y mouse model. Apart from craniosynostosis, this model shows cranial bone abnormalities. High‐resolution synchrotron microtomography images of the frontal and parietal bone were acquired for both FGFR2C342Y/+ (Crouzon, heterozygous mutant) and FGFR2+/+ (control, wild‐type) mice at five ages (postnatal days 1, 3, 7, 14 and 21, n = 6 each). Morphometric measurements were determined for cortical bone porosity: osteocyte lacunae and canals. General linear model to assess the effect of age, anatomical location and genotype was carried out for each morphometric measurement. Histological analysis was performed to validate the findings. In both groups (Crouzon and wild‐type), statistical difference in bone volume fraction, average canal volume, lacunar number density, lacunar volume density and canal volume density was found at most age points, with the frontal bone generally showing higher porosity and fewer lacunae. Frontal bone showed differences between the Crouzon and wild‐type groups in terms of lacunar morphometry (average lacunar volume, lacunar number density and lacunar volume density) with larger, less dense lacunae around the postnatal age of P7–P14. Histological analysis of bone showed marked differences in frontal bone only. These findings provide a better understanding of the pathogenesis of Crouzon syndrome and will contribute to computational models that predict postoperative changes with the aim to improve surgical outcome.

Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis

Soluble Form of FGFR2 with S252W Partially Prevents Craniosynostosis of the Apert Mouse Model

Adeno-Associated Virus-Mediated RNAi against Mutant Alleles Attenuates Abnormal Calvarial Phenotypes in an Apert Syndrome Mouse Model

RNA Interference and Inhibition of MEK-ERK Signaling Prevent Abnormal Skeletal Phenotypes in a Mouse Model of Craniosynostosis.

A Pro253Arg Mutation in Fibroblast Growth Factor Receptor 2 (fgfr2) Causes Skeleton Malformation Mimicking Human Apert Syndrome by Affecting Both Chondrogenesis and Osteogenesis

Prenatal Diagnosis of Apert Syndrome Due to A De Novo FGFR2 Mutation at the Second Trimester: a Case Report

Dosage‐dependent effects of FGFR2W290R mutation on craniofacial shape and cellular dynamics of the basicranial synchondroses

Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.

Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis

A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis

A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis.

Fgfr2c~(C342Y/+) Mouse Model of Crouzon Syndrome in Craniosynostosis

PIN1 is a new therapeutic target of craniosynostosis

PLGA-based Control Release of Noggin Blocks the Premature Fusion of Cranial Sutures Caused by Retinoic Acid

Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis

A Novel FGFR2 (S137W) Mutation Resulting in Apert Syndrome

Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis

Ocular abnormalities in Apert syndrome: genotype/phenotype correlations with fibroblast growth factor receptor type 2 mutations

The Effect of Yes-Associated Protein on the Interaction Between the MEK/Extracellular Signal-Regulated Kinase and Hippo Pathways in Osteoblasts Co-Cultured with Fibroblast Growth Factor Receptor 2-Mutated Dura Cells

FGFR2 Mutation P.cys342arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis Via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome

Inducible Activation of FGFR2 in Adult Mice Promotes Bone Formation After Bone Marrow Ablation